Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
10.98
-0.07 (-0.63%)
Sep 3, 2025, 11:16 AM - Market open
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $195.80 million as of September 3, 2025. Its market cap has increased by 1,278.91% in one year.
Market Cap
195.80M
Enterprise Value
90.91M
1-Year Change
1,278.91%
Ranking
Category
Stock Price
$10.98
Market Cap Chart
Since April 13, 2017, Forte Biosciences's market cap has decreased from $213.50M to $195.80M, a decrease of -8.29%. That is a compound annual growth rate of -1.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 136.80M | 312.05% |
| Dec 31, 2024 | 33.20M | 11.04% |
| Dec 29, 2023 | 29.90M | 42.38% |
| Dec 30, 2022 | 21.00M | -33.54% |
| Dec 31, 2021 | 31.60M | -93.24% |
| Dec 31, 2020 | 467.20M | 3,578.74% |
| Dec 31, 2019 | 12.70M | -92.25% |
| Dec 31, 2018 | 163.80M | -19.31% |
| Dec 29, 2017 | 203.00M | -4.92% |
| Apr 13, 2017 | 213.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 254.41B |
| AstraZeneca | 248.96B |
| Novartis AG | 245.38B |
| Abbott Laboratories | 230.89B |